‘Good Decision’: Experts React to FDA Pushing Back Decision on Moderna Vaccine for Kids

The choice to delay deciding whether or not to authorize Moderna’s COVID-19 vaccine for children has merit because of concerns about post-vaccination heart inflammation, experts said. U.S. drug regulators recently opted not to decide right now on authorization for Moderna’s shot for kids between 12 and 17, according to Moderna, which is also delaying plans to file for authorization for its jab for kids as young as 6. The company said the Food and Drug Administration (FDA) is investigating post-vaccination myocarditis among youth. “I think that is a good decision,” Dr. Monica Gandhi, professor of medicine and a**ociate division chief of the Division of HIV, Infectious Diseases, and Global Medicine at the University of California, San Francisco/San Francisco General Hospital, told The Epoch Times in an email. Moderna was proposing a 100-microgram dose in kids 12 to 17 in the United States. Pfizer’s shot for that group is 30 micrograms. Moderna …

Published
Categorized as archaive

By Kelly Sanchez

All you guys are warned: Be aware of Granma!

Leave a Reply